Get Live Data

Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Latest Share Chat

  2. Share Prices
  3. ValiRx Share Price
  4. ValiRx Share Regulatory News
  5. Result of General Meeting

Pin to quick picksValiRx Regulatory News (VAL)

ValiRx Information

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.875
Bid: 2.80
Ask: 2.95
Change: -0.075 (-2.54%)
Spread: 0.15 (5.357%)
Open: 2.95
High: 2.95
Low: 2.875
Prev. Close: 2.95
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of General Meeting

19 Nov 2012 12:19

RNS Number : 4568R
ValiRx PLC
19 November 2012
 



19 November 2012

VALIRX PLC

("ValiRx" or the "Company")

 

RESULT OF GENERAL MEETING

 

ValiRx (AIM: VAL), a life science company with a focus on cancer diagnostics and therapeutics for personalised medicine, announces that at the General Meeting of the Company held earlier today, all resolutions were duly passed.

 

Enquires:

ValiRx plc

Tel: +44 (0) 20 3008 4416

Dr Satu Vainikka

www.ValiRx.com

 

 

Cairn Financial Advisers LLP (Nominated Adviser)

Tel:+44 (0) 20 7148 7900

Liam Murray / Avi Robinson

 

 

 

Hybridan LLP (Broker)

Tel: +44 (0) 20 7947 4350

Claire Noyce / Deepak Reddy

 

 

 

Peckwater PR

Tel: +44 (0)7879 458 364

Tarquin Edwards

tarquin.edwards@peckwaterpr.co.uk

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGLKLFFLFFFFBD
12345678910
Date   Source Headline
10th Sep 20195:15 pmRNSHolding(s) in Company
10th Sep 20197:00 amRNSVAL201 Update
6th Aug 20197:00 amRNSCompany Update & Change of Adviser
1st Aug 20197:00 amRNSNew European patent allowance for VAL301
23rd Jul 20194:02 pmRNSHolding(s) in Company
23rd Jul 20197:00 amRNSAppointment of Joint Broker
10th Jul 20197:00 amRNSMarketing and Communications Update
9th Jul 201911:14 amRNSChange of Registered Address
4th Jul 20197:00 amRNSUpdate re VAL301
28th Jun 20191:33 pmRNSHolding(s) in Company
28th Jun 201912:31 pmRNSIssue of Equity
28th Jun 201912:03 pmRNSResult of AGM
26th Jun 201912:00 pmRNSHolding(s) in Company
26th Jun 20197:00 amRNSUS Notice of Allowance-VAL201 & Metastatic Cancer
25th Jun 20192:50 pmRNSFurther re: Termination of Subscription Agreement
24th Jun 201912:45 pmRNSHolding(s) in Company
21st Jun 201912:00 pmRNSHolding(s) in Company
20th Jun 20197:00 amRNSUpdate on VAL201 Clinical Trial
19th Jun 201912:00 pmRNSHolding(s) in Company
13th Jun 20197:00 amRNSPlacing, Subscription Agreement & Issue of Warrant
10th Jun 20197:00 amRNSSubscription Agreement Update
5th Jun 20197:00 amRNSNotice of AGM & Update of Subscription Agreement
31st May 201911:07 amRNSSubscription Agreement Update
31st May 201910:42 amRNSHolding(s) in Company
30th May 201910:30 amRNSHolding(s) in Company
29th May 201911:44 amRNSHolding(s) in Company
29th May 20197:00 amRNSFinal Results
28th May 20197:00 amRNSSubscription Agreement Update
23rd May 201912:02 pmRNSHolding(s) in Company
22nd May 20197:00 amRNSSubscription Agreement Update
13th May 20192:00 pmRNSPrice Monitoring Extension
2nd May 20197:00 amRNSAcquisition of Intellectual Property& JV Agreement
29th Apr 20192:06 pmRNSSecond Price Monitoring Extn
29th Apr 20192:01 pmRNSPrice Monitoring Extension
29th Apr 201911:07 amRNSSecond Price Monitoring Extn
29th Apr 201911:01 amRNSPrice Monitoring Extension
29th Apr 201910:55 amRNSHolding(s) in Company
26th Apr 20197:00 amRNSSubscription, Convertible Funds and Warrant Issue
15th Apr 20197:15 amEQSHardman & Co Research: Valirx (VAL): VAL401 is going forward
26th Mar 20197:00 amRNSValiSeek Update
21st Mar 20197:00 amRNSUpdate on VAL201 & VAL301 Development Progress
21st Feb 201911:22 amRNSPlacing, Issue of Equity and Warrant
31st Jan 20197:00 amRNSNew patent grant allowances for VAL301
11th Jan 20197:00 amRNSPublication of VAL401 peer-reviewed article
9th Jan 201910:41 amRNSValiRx endorses the Government's new NHS strategy
3rd Jan 20197:00 amRNSHolding(s) in Company
18th Dec 20184:41 pmRNSSecond Price Monitoring Extn
18th Dec 20184:36 pmRNSPrice Monitoring Extension
18th Dec 201811:25 amRNSIssue of Equity / PDMR Shareholdings
18th Dec 20187:00 amRNSUpdate on VAL401 - Peer-review Acceptance
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.